![Daniel Gooding](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 117 216 $ al 31/08/2026
Dr. Daniel Gooding is an Executive Director at Nuformix Plc.
He is on the Board of Directors at Nuformix Plc.
Dr. Gooding was previously employed as a Chief Executive Officer & Director by Nuformix Technologies Ltd. He received his doctorate degree from the University of Leeds.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NUFORMIX PLC 2,01 % | 11/11/2025 | 52.328.571 ( 2,01 % ) | 117 216 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NUFORMIX PLC | Fundador | 01/01/2008 |
| Empresas | Cargo | Fin |
|---|---|---|
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Fundador | 01/06/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nuformix Plc
 Nuformix Plc BiotechnologyHealth Technology Develops commercial technologies in pharmaceutical and biotechnology sector | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
